Author

Heena V. Dave

Observed names: D.H. Dave, Dave Heena, H. Dave, Heena Dave, Heena V Dave

Institution: Nirma University

Observed institutions: Gujarat Cancer & Research Institute, Nirma University, Weill Cornell Medicine

ORCID: 0000-0002-6029-6515

Observed ORCID: 0000-0002-6029-6515

OpenAlex ID: A5057820193

Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients

2012 · Heena Dave, Manoj Shah, et al. · The International Journal of Biological Markers · 33

Localized delivery of Erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma

2023 · Kartik Hariharan, Tejal Mehta, et al. · International Journal of Pharmaceutics · 26

TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond

2022 · Nirali Shukla, Ankit Naik, et al. · Life Sciences · 24

Transforming growth factor beta 2: a predictive marker for breast cancer.

2011 · Heena Dave, Sunil Trivedi, et al. · PubMed · 20

Androgen receptor: Structure, signaling, function and potential drug discovery biomarker in different breast cancer subtypes

2024 · Nirali Shukla, Kanisha Shah, et al. · Life Sciences · 17

Carica papaya: Potential Implications in Human Health

2019 · Dave Heena, Trivedi Sunil · Current Traditional Medicine · 15

Evaluation of Anti Cancer Activity of Polyherbal Formulation

2011 · J.V. Savjiyani, H. Dave, et al. · International Journal of Cancer Research · 11

PDF

MicroRNA-driven organ-specific metastasis in triple-negative breast cancer: biogenesis, mechanisms, and therapeutic approaches

2025 · Deepshikha Rathore, Sweny Jain, et al. · Medical Oncology · 7

Antagonists of CD39 and CD73 potentiate doxycycline repositioning to induce a potent antitumor immune response

2024 · Parameswar Dalai, Dhruvi Shah, et al. · Cellular Signalling · 4

PDF

Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells

2025 · Nandani Dharwal, Deepshikha Rathore, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2

Current developments and future directions in androgen receptor targets using nano-based therapeutics for the management of cancer

2025 · Nirali Shukla, Anam Sami, et al. · Drug Development and Industrial Pharmacy · 2

Breast cancer: Role of microRNAs as biomarker

2025 · Deepshikha Rathore, Sweny Jain, et al. · Elsevier eBooks · 2

From virtual screening to bench: A dual-validation framework for drug repurposing against PI3K

2026 · Kavita Tewani, Zunnun Narmawala, et al. · Computational Biology and Chemistry · 1

Abstract 1754: Transforming growth factor beta as potential prognostic biomarker of breast cancer: Evidence of ‘TGF-β switch’

2010 · Heena Dave, Sunil Trivedi, et al. · Cancer Research · 1

hsa-miR-9–FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis

2026 · Deepshikha Rathore, Vasundhara Dheer, et al. · Biochemical and Biophysical Research Communications

Androgen receptor as therapeutic indicator for LAR-positive triple-negative breast cancer: Preclinical and clinical assessment

2026 · Nirali Shukla, Devanshi Sharma, et al. · The Journal of Steroid Biochemistry and Molecular Biology

Correction to: Molecular interplay of lncRNAs, miRNAs, and mRNAs axes in triple-negative breast cancer: implications for metastatic progression

2026 · Deepshikha Rathore, Ishita Agarwal, et al. · Journal of Applied Genetics

PDF

Molecular interplay of lncRNAs, miRNAs, and mRNAs axes in triple-negative breast cancer: implications for metastatic progression

2026 · Deepshikha Rathore, Ishita Agarwal, et al. · Journal of Applied Genetics

Inflammatory pathways in oral cancer development

2026 · Deepak Solanki, Ritu Soni, et al. · Elsevier eBooks

142P Implications of microRNAs in the prognostication of luminal androgen receptor-positive triple-negative breast cancer

2025 · N. Shukla, D.H. Dave · ESMO Open

PDF

Downregulation of miR-1269a pronounces breast cancer bone metastasis

2025 · Smit Patel, Ishita Agarwal, et al. · Human Gene

Oral cancer: Current and new drug delivery system

2025 · Anam Sami, Kartik Hariharan, et al. · Elsevier eBooks

Contributors

2025 · Samson A. Adeyemi, Mudassir Ansari, et al. · Elsevier eBooks

Contributors

2025 · Ghulam Abbas, Nathaniel Ebo Aidoo, et al. · Elsevier eBooks

WITHDRAWN: Deciphering the Role of MicroRNAs in the Development of Organotropic Metastasis in Triple-negative Breast Cancer

2024 · Deepshikha Rathore, Sweny Jain, et al. · Aspects of Molecular Medicine

Works count: 28

Citation count: 165

H-index: 7

I10-index: 7